{"id":1279,"date":"2018-03-20T08:53:29","date_gmt":"2018-03-20T07:53:29","guid":{"rendered":"http:\/\/psychotropes.info\/wordpress\/?p=1279"},"modified":"2018-06-22T17:27:45","modified_gmt":"2018-06-22T15:27:45","slug":"references-bibliographiques-du-manuel","status":"publish","type":"post","link":"https:\/\/psychotropes.info\/wordpress\/2018\/03\/references-bibliographiques-du-manuel\/","title":{"rendered":"R\u00e9f\u00e9rences bibliographiques du manuel"},"content":{"rendered":"

ADMED Laboratoires. (2016). Dosages d\u2019antid\u00e9presseurs. Acc\u00e8s\u00a0: http:\/\/admed.ne.ch\/files\/flhn\/flhn-info\/078_2016_01_AdmedInfo_Antid%C3%A9presseurs.pdf<\/p>\n

ALPABEM. (2017). Psychose toxique<\/em>. Acc\u00e8s\u00a0: http:\/\/alpabem.qc.ca\/psychose-toxique\/<\/p>\n

American Psychiatric Association [APA]. (2016). Mini DSM-5\u00a0: crit\u00e8res diagnostiques. <\/em>Issy-les-Moulineaux: Elsevier Masson SAS<\/p>\n

ASDR. (2013). G\u00e9n\u00e9ralit\u00e9s concernant l’\u00e9crasement des comprim\u00e9s ou l’ouverture des g\u00e9lules<\/em>. Acc\u00e8s: http:\/\/www.asdr.asso.fr\/wp-content\/uploads\/2013\/08\/Administration-formes-s%C3%A9ches_ENR094.pdf<\/p>\n

Ashton, C.H.. (2002). Benzodiazepines: How They Work And How To Withdraw (aka The Ashton Manual).<\/em> Acc\u00e8s: http:\/\/benzo.org.uk\/manual\/index.htm<\/p>\n

Association Neptune. (2014). Titrage, titration, dosage<\/em>. Acc\u00e8s: http:\/\/www.forumpsy.net\/t648-titrage-titration-dosage<\/p>\n

Barlow, D. H. et Durand, V. M. (2007). Psychopathologie\u00a0: une perspective multidimensionnelle<\/em>. Bruxelles\u00a0: De Boeck.<\/p>\n

Birman, S. (2011). La vie sans dopamine<\/em>. Acc\u00e8s\u00a0: http:\/\/www.cnrs.fr\/insb\/recherche\/parutions\/articles2011\/e-birman.htm<\/p>\n

Boisvert, W. (2008). La d\u00e9pression qui ne r\u00e9pond pas au traitement. Le clinicien, 53-59. Acc\u00e8s: http:\/\/www.stacommunications.com\/journals\/leclinicien\/2008\/06-june%202008\/053-La%20d%C3%A9pression%20r%C3%A9fractaire.pdf<\/p>\n

Bonnet, A.-M.. (2001). Sympt\u00f4mes de la maladie de Parkinson. G\u00e9rontologie et soci\u00e9t\u00e9, 24<\/em>(97), 129 \u2013 138. Acc\u00e8s\u00a0: https:\/\/www.cairn.info\/revue-gerontologie-et-societe1-2001-2-page-129.htm<\/p>\n

Breggin, P. R. et Cohen. D. (2007). Your Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Medications<\/em>. Fully revised and updated edition. Ed. Da Capo Press<\/p>\n

Breggin, P. R. (2017). Dr. Peter Breggin\u2019s Antidepressant Drug Resource & Information Center : For Prescribers, Scientists, Professionals, Patients and their Families<\/em>. Acc\u00e8s : https:\/\/breggin.com\/antidepressant-drugs-resource-center\/<\/p>\n

Breggin, P. R. (2017). List of Antidepressant Drugs<\/em>. Acc\u00e8s: https:\/\/breggin.com\/antidepressant-drugs-resource-center\/list-of-antidepressant-drugs\/<\/p>\n

Breggin, P. R. (2013). Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families.<\/em><\/p>\n

Breggin, P. R. et Cohen. D. (2007). Your Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Medications<\/em>. Fully revised and updated edition. Ed. Da Capo Press<\/p>\n

Broers, B. (2011). Du bon usage des benzodiaz\u00e9pines<\/em>?. Acc\u00e8s: http:\/\/www.hug-ge.ch\/sites\/interhug\/files\/atelier_mpr\/072012_benzodiazepines.pdf<\/p>\n

Chassot, M., Livio, F., Buclin, T. et Munz, T. (2012). Syndrome s\u00e9rotoninergique : mise au point et revue des cas annonc\u00e9s en Suisse. Revue M\u00e9dicale Suisse, 8,<\/em> 2086-2090. Acc\u00e8s: https:\/\/www.revmed.ch\/contentrevmed\/download\/124731\/1249065<\/p>\n

Chatti, S., Zarrouk, L., Marrag, I., Jmal, M., Marmouch, H., Sayadi, H., Khochtali, I. et Nasr, M. (2014). Facteurs de risque du syndrome m\u00e9tabolique chez les patients sous antipsychotiques. Annales d’Endocrinologie<\/em>. 75<\/em>(5-6), 462. Acc\u00e8s: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003426614007483?via%3Dihub<\/p>\n

Code-QR.net. (2018). Lecture d’un flashcode \u00e0 l’aide d’un smartphone<\/em>. Acc\u00e8s\u00a0: http:\/\/www.code-qr.net\/lire-un-code-qr.php<\/p>\n

Coll\u00e8ge National de Pharmacologie M\u00e9dicale. (2017). Antipsychotiques\u00a0: les points essentiels<\/em>. Acc\u00e8s\u00a0: https:\/\/pharmacomedicale.org\/medicaments\/par-specialites\/item\/antipsychotiques-les-points-essentiels<\/p>\n

Compendium Suisse des M\u00e9dicaments. (2017). Compendium.ch<\/em>. Acc\u00e8s : https:\/\/compendium.ch\/home\/fr<\/p>\n

F\u00e8ve, B. (2013). Effets m\u00e9taboliques ind\u00e9sirables des antipsychotiques. Ob\u00e9sit\u00e9, 8<\/em>(3), 165 \u2013 173. Acc\u00e8s\u00a0: https:\/\/link.springer.com\/article\/10.1007\/s11690-013-0365-x<\/p>\n

Floris, M., Lecompte, D., Mertens, C., De Nayer, A., Mallet, L., Vandendriessche, F. et Detraux, J. (2004). La dystonie aigu\u00eb. Suppl\u00e9ment \u00e0 Neurone, 9<\/em>(7). Acc\u00e8s\u00a0: http:\/\/www.synopsys.be\/documents\/get\/fa4269dac5945e0761d38afe1431f088.pdf<\/p>\n

Gouget, C. (2012). Additifs alimentaires Danger, le guide indispensable pour ne plus vous empoisonner<\/em>. Paris\u00a0: Chariot d\u2019Or<\/p>\n

Grima, M. (2008). Les antid\u00e9presseurs<\/em>. Acc\u00e8s : http:\/\/udsmed.u-strasbg.fr\/pharmaco\/pdf\/dcm3\/DCEM3-Pharmaco_Chap5-Antidepresseurs_2008.pdf<\/p>\n

HAS. (2015). Arr\u00eat des benzodiaz\u00e9pines et m\u00e9dicaments apparent\u00e9s : d\u00e9marche du m\u00e9decin traitant en ambulatoire. <\/em>Acc\u00e8s : https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2015-06\/fiche_memo_rapport_elaboration_arret_benzodiazepines__2015_06_17.pdf<\/p>\n

HAS. (2015). Utiles dans l\u2019anxi\u00e9t\u00e9, les benzodiaz\u00e9pines restent une solution temporaire<\/em>. Acc\u00e8s : https:\/\/www.has-sante.fr\/portail\/jcms\/c_2042111\/fr\/utiles-dans-lanxiete-les-benzodiazepines-restent-une-solution-temporaire<\/p>\n

Hayasaka, Y., Purgato, M., Magni, L.R., Ogawa, Y., Takeshima, N.I., Cipriani, A., Barbui, C., Leucht, S. & Furukawa, T.A.. (2015). Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of Affective Disorders, 180<\/em>, 179-184. Acc\u00e8s: http:\/\/www.jad-journal.com\/article\/S0165-0327(15)00151-2\/pdf<\/p>\n

Healy, D. (2011). Halting SSRIs<\/em>. Acc\u00e8s: http:\/\/www.mediafire.com\/file\/6hl3uu0bkporwhi\/09_Healy_Halting_SSRIs.pdf<\/p>\n

HUG. (2017). Comprim\u00e9: couper ou \u00e9craser? S\u00e9cabilit\u00e9, possibilit\u00e9 de broyage des comprim\u00e9s et d’ouverture des capsules<\/i>. Acc\u00e8s: https:\/\/pharmacie.hug-ge.ch\/infomedic\/utilismedic\/tab_couper_ecraser.pdf<\/p>\n

HUG. (2017). Formes gal\u00e9niques orales particuli\u00e8res<\/em>. Acc\u00e8s: https:\/\/pharmacie.hug-ge.ch\/infomedic\/utilismedic\/forme_gal.pdf<\/p>\n

HUG. (2005). Formes gal\u00e9niques sp\u00e9ciales<\/em>. Acc\u00e8s: https:\/\/pharmacie.hug-ge.ch\/infomedic\/cappinfo\/cappinfo36.pdf<\/p>\n

HUG. (2015). Guide pour l\u2019emploi des psychotropes d\u2019usage courant<\/em>. Acc\u00e8s\u00a0: https:\/\/www.hug-ge.ch\/sites\/interhug\/files\/structures\/pharmacologie_et_toxicologie_cliniques\/documents\/guide_des_psychotropes_2015.pdf<\/p>\n

HUG. (2009). Syndromes d’intoxication en g\u00e9riatrie: syndrome malin des neuroleptiques<\/em>. Acc\u00e8s\u00a0: https:\/\/www.hug-ge.ch\/sites\/interhug\/files\/structures\/pharmacologie_et_toxicologie_cliniques\/documents\/cappinfo55.pdf<\/p>\n

Imbault, G. (2008). La cessation et la substitution d\u2019un antid\u00e9presseur. Qu\u00e9bec Pharmacie, 55<\/em>(9). Acc\u00e8s: http:\/\/www.professionsante.ca\/files\/2009\/11\/qp_page_bleue_oct08.pdf<\/p>\n

INSERM. (s.d.). Pharmacod\u00e9pendance : m\u00e9canismes neurobiologiques<\/em>. Acc\u00e8s : http:\/\/www.ipubli.inserm.fr\/bitstream\/handle\/10608\/2072\/?sequence=30<\/p>\n

Journal de Femmes avec Sant\u00e9 M\u00e9decine. (2017). Akathisie \u2013 D\u00e9finition<\/em>. Acc\u00e8s :
\nhttp:\/\/sante-medecine.journaldesfemmes.com\/faq\/17145-akathisie-definition<\/p>\n

Journal de Femmes avec Sant\u00e9 M\u00e9decine. (2012). M\u00e9canisme d’action des benzodiaz\u00e9pines – D\u00e9finition<\/em>. Acc\u00e8s: http:\/\/sante-medecine.journaldesfemmes.com\/faq\/48507-mecanisme-d-action-des-benzodiazepines-definition<\/p>\n

Journal de Femmes avec Sant\u00e9 M\u00e9decine. (2017). Nociception \u2013 D\u00e9finition<\/em>. Acc\u00e8s\u00a0:
\nhttp:\/\/sante-medecine.journaldesfemmes.com\/faq\/20860-nociception-definition<\/p>\n

Kirsch, I. (2010). Antid\u00e9presseurs Le grand mensonge<\/em>. Champs-sur-Marne\u00a0: Music & Entertainment Books<\/p>\n

Laqueille, X. et Liot, K. (2009). Addictions : d\u00e9finitions et principes th\u00e9rapeutiques. L’information psychiatrique, 85<\/em>(7), 611-620. Acc\u00e8s\u00a0: https:\/\/www.cairn.info\/revue-l-information-psychiatrique-2009-7-page-611.htm<\/p>\n

Le cerveau \u00e0 tous les niveaux. (s.d.). Les neurotransmetteurs affect\u00e9s par les drogues<\/em>. Acc\u00e8s : http:\/\/lecerveau.mcgill.ca\/flash\/i\/i_03\/i_03_m\/i_03_m_par\/i_03_m_par.html#drogues<\/p>\n

Liberek, C., Desmeules, J., Vogt, N., Rollason, V. et Dayer, P. (2000). Le syndrome s\u00e9rotoninergique m\u00e9dicamenteux\u00a0: un risque \u00e0 ne pas n\u00e9gliger. Revue M\u00e9dicale Suisse, 4<\/em>, 20501. Acc\u00e8s\u00a0: https:\/\/www.revmed.ch\/RMS\/2000\/RMS-2296\/20501<\/p>\n

Manuel Ashton (VF). (2012). Les Benzodiaz\u00e9pines: Comment agissent-elles et comment s’en sevrer?<\/em>. Acc\u00e8s: http:\/\/www.benzo.org.uk\/freman\/index.htm<\/p>\n

McGill. (s.d.). La consommation de drogues. Le cerveau \u00e0 tous les niveaux<\/em>. Acc\u00e8s\u00a0: http:\/\/lecerveau.mcgill.ca\/flash\/i\/i_03\/i_03_p\/i_03_p_par\/i_03_p_par.html<\/p>\n

Mepha Pharma. (2018). Des formes d\u2019administration optimis\u00e9es<\/em>. Acc\u00e8s: http:\/\/www.mepha.ch\/fr\/guides-connaissances\/galenique<\/p>\n

Nimmo, R. (2002). BENZODIAZEPINE DEPENDENCY AND WITHDRAWAL Frequently Asked Questions (FAQ) file<\/em>. Acc\u00e8s: http:\/\/www.benzo.org.uk\/FAQ1.1.htm<\/p>\n

Nimmo, R. (s.d.). Excerpts from Toxic Psychiatry: chapitre 11 by Peter R. Breggin, M.D<\/em>. Acc\u00e8s: http:\/\/www.benzo.org.uk\/breggin2.htm<\/p>\n

OMS. (2018). Syndrome de d\u00e9pendance<\/em>. Acc\u00e8s\u00a0: http:\/\/www.who.int\/substance_abuse\/terminology\/definition1\/fr\/<\/p>\n

OMS. (2017). Substances psychoactives<\/em>. Acc\u00e8s: http:\/\/www.who.int\/substance_abuse\/terminology\/psychoactive_substances\/fr\/<\/p>\n

Ooreka. (2018). Syndrome extrapyramidal<\/em>. Acc\u00e8s\u00a0: https:\/\/parkinson.ooreka.fr\/astuce\/voir\/657297\/syndrome-extrapyramidal<\/p>\n

Perlmutter, D. (2016). Ces glucides qui menacent notre cerveau: Pourquoi et comment limiter gluten, sucres et glucides raffin\u00e9s<\/em>. Paris\u00a0: Marabout<\/p>\n

PharmaEtudes. (2007). Neuroleptiques et autres antipsychotiques<\/em>. Acc\u00e8s\u00a0: http:\/\/www.pharmaetudes.com\/ressources\/cours%20internat\/section5\/11-neuroleptiques-et-autres-antipsychotiques.pdf<\/p>\n

Phelps, J. (2005). Discontinuing Effexor XR<\/em>. Acc\u00e8s: http:\/\/bipolarworld.net\/Phelps\/ph_2005\/ph1354.htm<\/p>\n

Pringsheim, T., Doja, A., Belanger, S. & Patten, S. (2012). Les recommandations th\u00e9rapeutiques relatives aux effets secondaires extrapyramidaux associ\u00e9s \u00e0 l\u2019utilisation d\u2019antipsychotiques de deuxi\u00e8me g\u00e9n\u00e9ration chez les enfants et les adolescents. Paediatr Child Health, 17<\/em>(Suppl B), 22B-30B. Acc\u00e8s: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3486683<\/p>\n

Sevrage Aux Benzodiaz\u00e9pines. (2009). Le sevrage aux benzodiaz\u00e9pines : les diff\u00e9rentes m\u00e9thodes de sevrage<\/em>. Acc\u00e8s : https:\/\/sites.google.com\/site\/sevrageauxbenzodiazepines\/le-sevrage-aux-benzodiazepines<\/p>\n

UNIGE. (2010). Toxicomanie: \u00ab\u00a0Rencontre d’un individu, d’un produit, d’une soci\u00e9t\u00e9\u00a0\u00bb<\/em>. Acc\u00e8s: www.medecine.unige.ch\/enseignement\/apprentissage\/module4\/immersion\/archives\/2009_2010\/travaux\/10_r_toxicomanie_a.pdf<\/p>\n

Vidal. (2018). Lib\u00e9ration prolong\u00e9e<\/em>. Lexique m\u00e9dical. Acc\u00e8s: https:\/\/eurekasante.vidal.fr\/lexique-medical\/L.html#liberation-prolongee<\/p>\n

Vulgaris M\u00e9dical. (2017). Clonus<\/em>. Acc\u00e8s\u00a0: https:\/\/www.vulgaris-medical.com\/encyclopedie-medicale\/clonus<\/p>\n

Vulgaris M\u00e9dical. (s.d.). M\u00e9dicament<\/em>. Acc\u00e8s:
\nhttp:\/\/www.vulgaris-medical.com\/encyclopedie-medicale\/medicament<\/p>\n

Vulgaris M\u00e9dical. (2017). Myoclonie<\/em>. Acc\u00e8s:
\nhttps:\/\/www.vulgaris-medical.com\/encyclopedie-medicale\/myoclonie<\/p>\n

W-Bad. (2017). Common BZDS and Z-DRUGS<\/em>. Acc\u00e8s: http:\/\/w-bad.org\/bzds-zdrugs\/<\/p>\n

W-Bad. (2017). Journ\u00e9e Mondiale de Sensibilisation aux Benzodiaz\u00e9pines: le saviez-vous?.<\/em> Acc\u00e8s:
\nhttp:\/\/w-bad.org\/wp-content\/uploads\/2017\/05\/FRENCH-FRONT.pdf<\/p>\n

WebPhysique. (2016). Forme gal\u00e9nique d\u2019un m\u00e9dicament<\/em>. Acc\u00e8s:
\nhttp:\/\/webphysique.fr\/forme-galenique-dun-medicament\/<\/p>\n

Wikip\u00e9dia. (2017). Akathisie<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/Akathisie<\/p>\n

Wikip\u00e9dia. (2015). Antid\u00e9presseur<\/em> t\u00e9tracyclique<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Antid%C3%A9presseur_t%C3%A9tracyclique<\/p>\n

Wikip\u00e9dia. (2017). Antid\u00e9presseur<\/em> tricyclique<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Antid%C3%A9presseur_tricyclique<\/p>\n

Wikip\u00e9dia. (2017). Bupropion<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Bupropion<\/p>\n

Wikip\u00e9dia. (2017). Classification des agents psychotropes selon Delay et Deniker (1957).<\/em> Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Classification_des_psychotropes#Classification_des_agents_psychotropes_selon_Delay_et_Deniker_.281957.29<\/p>\n

Wikip\u00e9dia. (2017). Clotiaz\u00e9pam<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/Clotiaz%C3%A9pam<\/p>\n

Wikip\u00e9dia. (2017). Compl\u00e9ment alimentaire<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/Compl%C3%A9ment_alimentaire<\/p>\n

Wikip\u00e9dia. (2017). D\u00e9personnalisation<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/D%C3%A9personnalisation<\/p>\n

Wikip\u00e9dia. (2018). D\u00e9r\u00e9alisation<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/D%C3%A9r%C3%A9alisation<\/p>\n

Wikip\u00e9dia. (2017). Desvenlafaxine<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Desvenlafaxine<\/p>\n

Wikip\u00e9dia. (2017). Diaphor\u00e8se<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Diaphor%C3%A8se<\/p>\n

Wikip\u00e9dia. (2016). Effet rebond (m\u00e9decine).<\/em> Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/Effet_rebond_(m%C3%A9decine)<\/p>\n

Wikip\u00e9dia. (2017). Halop\u00e9ridol<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/Halop%C3%A9ridol<\/p>\n

Wikip\u00e9dia. (2016). Heather Ashton<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Heather_Ashton<\/p>\n

Wikip\u00e9dia. (2017). Hyperr\u00e9flexie<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Hyperr%C3%A9flexie<\/p>\n

Wikip\u00e9dia. (2017). Hypomanie<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Hypomanie<\/p>\n

Wikip\u00e9dia. (2017). Hypotension orthostatique<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Hypotension_orthostatique<\/p>\n

Wikip\u00e9dia. (2017). Inhibiteur de la recapture de la s\u00e9rotonine et de la noradr\u00e9naline<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Inhibiteur_de_la_recapture_de_la_s%C3%A9rotonine_et_de_la_noradr%C3%A9naline<\/p>\n

Wikip\u00e9dia. (2017). Liste d\u2019ISRS<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Inhibiteur_s%C3%A9lectif_de_la_recapture_de_la_s%C3%A9rotonine#Liste_d.27ISRS<\/p>\n

Wikip\u00e9dia. (2017). Manie<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Manie<\/p>\n

Wikip\u00e9dia. (2017). Mirtazapine<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Mirtazapine<\/p>\n

Wikip\u00e9dia. (2017). Olanzapine<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Olanzapine<\/p>\n

Wikipedia. (2017). Pirenzepine<\/em>. Acc\u00e8s: https:\/\/en.wikipedia.org\/wiki\/Pirenzepine<\/p>\n

Wikip\u00e9dia. (2017). Psychotrope<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Psychotrope<\/p>\n

Wikip\u00e9dia. (2017). S\u00e9datif<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/S%C3%A9datif<\/p>\n

Wikip\u00e9dia. (2017). Substances assimil\u00e9es \u00e0 des benzodiaz\u00e9pines<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Benzodiaz%C3%A9pine#Substances_assimil.C3.A9es_.C3.A0_des_benzodiaz.C3.A9pines<\/p>\n

Wikip\u00e9dia. (2017). Synapse<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Synapse<\/p>\n

Wikip\u00e9dia. (2017). Syndrome extrapyramidal<\/em>. Acc\u00e8s\u00a0: https:\/\/fr.wikipedia.org\/wiki\/Syndrome_extrapyramidal<\/p>\n

Wikip\u00e9dia. (2018). Syndrome m\u00e9tabolique<\/em>. Acc\u00e8s: https:\/\/fr.wikipedia.org\/wiki\/Syndrome_m%C3%A9tabolique<\/p>\n

Wikip\u00e9dia. (2017). Vilazodone<\/em>. Acc\u00e8s : https:\/\/fr.wikipedia.org\/wiki\/Vilazodone<\/p>\n","protected":false},"excerpt":{"rendered":"

ADMED Laboratoires. (2016). Dosages d\u2019antid\u00e9presseurs. Acc\u00e8s\u00a0: http:\/\/admed.ne.ch\/files\/flhn\/flhn-info\/078_2016_01_AdmedInfo_Antid%C3%A9presseurs.pdf ALPABEM. (2017). Psychose toxique. Acc\u00e8s\u00a0: http:\/\/alpabem.qc.ca\/psychose-toxique\/ American Psychiatric Association [APA]. (2016). Mini DSM-5\u00a0: crit\u00e8res diagnostiques. Issy-les-Moulineaux: Elsevier Masson SAS ASDR. (2013). G\u00e9n\u00e9ralit\u00e9s concernant l’\u00e9crasement des comprim\u00e9s ou l’ouverture des g\u00e9lules. Acc\u00e8s: http:\/\/www.asdr.asso.fr\/wp-content\/uploads\/2013\/08\/Administration-formes-s%C3%A9ches_ENR094.pdf Ashton, C.H.. (2002). Benzodiazepines: How They Work And How To Withdraw (aka The Ashton Manual). Acc\u00e8s: […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[97],"tags":[223,222],"class_list":["post-1279","post","type-post","status-publish","format-standard","hentry","category-manuel-de-sevrage","tag-bibliographie","tag-references"],"_links":{"self":[{"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/posts\/1279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/comments?post=1279"}],"version-history":[{"count":14,"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/posts\/1279\/revisions"}],"predecessor-version":[{"id":1966,"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/posts\/1279\/revisions\/1966"}],"wp:attachment":[{"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/media?parent=1279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/categories?post=1279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychotropes.info\/wordpress\/wp-json\/wp\/v2\/tags?post=1279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}